IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Cancer and Metastasis Reviews

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

7.89

h-Index

2022-2023

 158

Rank

2022-2023

 1195

SJR

2022-2023

 2.107

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Cancer and Metastasis Reviews
Abbreviation Cancer Metastasis Rev.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q1); Oncology (Q1)
h-index 158
Overall Rank/Ranking 1195
SCImago Journal Rank (SJR) 2.107
Impact Score 7.89
Publisher Springer Netherlands
Country Netherlands
ISSN 01677659, 15737233
Best Quartile Q1
Coverage History 1982-2022




About Cancer and Metastasis Reviews


Cancer and Metastasis Reviews is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Oncology (Q1). It is published by Springer Netherlands. The overall rank of Cancer and Metastasis Reviews is 1195. According to SCImago Journal Rank (SJR), this journal is ranked 2.107. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 158. The best quartile for this journal is Q1.

The ISSN of Cancer and Metastasis Reviews journal is 01677659, 15737233. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer and Metastasis Reviews is cited by a total of 1857 articles during the last 3 years (Preceding 2022).


Cancer and Metastasis Reviews Impact IF 2022-2023


The Impact IF 2022 of Cancer and Metastasis Reviews is 7.89, which is computed in 2023 as per its definition. Cancer and Metastasis Reviews IF is decreased by a factor of 0.35 and approximate percentage change is -4.25% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Cancer and Metastasis Reviews Impact IF 2023 Prediction


Impact IF 2022 of Cancer and Metastasis Reviews is 7.89. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Cancer and Metastasis Reviews. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 7.89
2021 8.24
2020 7.85
2019 5.88
2018 6.14
2017 5.71
2016 4.83
2015 5.67
2014 8.12

Cancer and Metastasis Reviews h-index


  Table Setting

Cancer and Metastasis Reviews has an h-index of 158. It means 158 articles of this journal have more than 158 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Cancer and Metastasis Reviews ISSN


The ISSN of Cancer and Metastasis Reviews is 01677659, 15737233. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Cancer and Metastasis Reviews Rank and SCImago Journal Rank (SJR)


The overall rank of Cancer and Metastasis Reviews is 1195. According to SCImago Journal Rank (SJR), this journal is ranked 2.107. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Cancer and Metastasis Reviews by Year


Year SJR
2023/2024 Coming Soon
2022 2.107
2021 1.796
2020 2.555
2019 2.810
2018 2.427
2017 2.402
2016 2.605
2015 2.769
2014 3.644

Ranking of Cancer and Metastasis Reviews by Year


Year Ranking
2023/2024 Coming Soon
2022 1195
2021 1506
2020 878
2019 744
2018 959
2017 991
2016 848
2015 766
2014 460

Cancer and Metastasis Reviews Publisher


Table Setting

Cancer and Metastasis Reviews is published by Springer Netherlands. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 1982-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Cancer and Metastasis Reviews is Cancer Metastasis Rev.. This abbreviation ('Cancer Metastasis Rev.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Cancer and Metastasis Reviews


If your research field is/are related to Cancer Research (Q1); Oncology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Cancer and Metastasis Reviews?

Cancer and Metastasis Reviews latest impact IF is 7.89. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 8.24 (2021) and 4.83 (2016), respectively, in the last 9 years. Moreover, its average IS is 6.7 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Cancer and Metastasis Reviews?

The Cancer and Metastasis Reviews has an SJR (SCImago Journal Rank) of 2.107, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 3.644 in 2014 and the lowest being 1.796 in 2021. Furthermore, the average SJR of the Cancer and Metastasis Reviews over the previous 9-year period stands at 6.7.


What's the latest h-index of the Cancer and Metastasis Reviews?

The latest h-index of the Cancer and Metastasis Reviews is 158.


Who's the publisher of the Cancer and Metastasis Reviews?

The Cancer and Metastasis Reviews is published by the Springer Netherlands, with its country of publication being the Netherlands.


What's the current ranking of the Cancer and Metastasis Reviews?

The Cancer and Metastasis Reviews is currently ranked 1195 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 460 in 2014 and its lowest position of 1506 in 2021.


What's the abbreviation or short name for the Cancer and Metastasis Reviews?

The standard ISO4 abbreviation for the Cancer and Metastasis Reviews is Cancer Metastasis Rev..


Is the "Cancer and Metastasis Reviews" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Cancer and Metastasis Reviews is classified as a journal that the Springer Netherlands publishes.


What's the scope or major areas of the Cancer and Metastasis Reviews?

The Cancer and Metastasis Reviews encompasses the following areas:

  • Cancer Research
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Cancer and Metastasis Reviews?

The Cancer and Metastasis Reviews is assigned the following International Standard Serial Numbers (ISSN): 01677659, 15737233.


What's the best quartile of the Cancer and Metastasis Reviews?

The best quartile for the Cancer and Metastasis Reviews is Q1 (2022).


What's the coverage history of the Cancer and Metastasis Reviews?

The Cancer and Metastasis Reviews coverage history can be summarized as follows: 1982-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 10343 Vilnius Gediminas Technical University 45 2.81
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
CESifo Economic Studies journal 14012 Oxford University Press 32 1.70
Entrepreneurship Theory and Practice journal 338 Wiley-Blackwell 185 12.75
Modern Language Journal journal 918 Wiley-Blackwell 103 3.89
Oral Radiology journal 9461 Springer Japan 20 2.06
Proteomics - Clinical Applications journal 9140 Wiley-VCH Verlag 59 2.02
Physics and Chemistry of the Earth journal 12927 Pergamon Press Ltd. 33 0.00
Journal of Imaging Science and Technology journal 19249 Society for Imaging Science and Technology 44 0.96
Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining conference and proceedings 4334 192 0.00

Check complete list




Year wise Impact Score (IS) of Cancer and Metastasis Reviews

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 7.89
2021 8.24
2020 7.85
2019 5.88
2018 6.14
2017 5.71
2016 4.83
2015 5.67
2014 8.12



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All